Chemoinformaics analysis of Rhamnetin 3-galactosyl-(1->4)-galactoside
Molecular Weight | 640.547 | nRot | 8 |
Heavy Atom Molecular Weight | 608.291 | nRig | 30 |
Exact Molecular Weight | 640.164 | nRing | 5 |
Solubility: LogS | -3.661 | nHRing | 3 |
Solubility: LogP | -0.525 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 2 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
nHA | 17 | APOL | 81.7314 |
nHD | 10 | BPOL | 43.3866 |
QED | 0.115 |
Synth | 4.761 |
Natural Product Likeliness | 1.837 |
NR-PPAR-gamma | 0.742 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0.984 |
HIA | 0.921 |
CACO-2 | -6.408 |
MDCK | 0.0000498 |
BBB | 0.175 |
PPB | 0.791348 |
VDSS | 0.626 |
FU | 0.220416 |
CYP1A2-inh | 0.019 |
CYP1A2-sub | 0.026 |
CYP2c19-inh | 0.008 |
CYP2c19-sub | 0.055 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.14 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.163 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.004 |
CL | 1.35 |
T12 | 0.74 |
hERG | 0.103 |
Ames | 0.795 |
ROA | 0.035 |
SkinSen | 0.081 |
Carcinogencity | 0.029 |
EI | 0.012 |
Respiratory | 0.012 |
NR-Aromatase | 0.8 |
Antiviral | Yes |
Prediction | 0.822181 |